Comparative efficacy of combined antihistamine and montelukast therapy in adult patients with atopic dermatitis
Open Access
- 1 January 2024
- journal article
- research article
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 41 (1) , 32-40
Abstract
Introduction: Atopic dermatitis (AD) is one of the most common chronic skin conditions affecting about 20% of children and 5% of adults. However, the studies assessing novel therapies for AD have been focused mainly on paediatric patients and only few studies have involved adult participants....Keywords
This publication has 44 references indexed in Scilit:
- What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability studyBritish Journal of Dermatology, 2015
- Association between allergic sensitization and exhaled nitric oxide in children in the School Inner-City Asthma StudyAnnals of Allergy, Asthma & Immunology, 2015
- Pathogenesis of atopic dermatitisClinical & Experimental Allergy, 2015
- Deciphering the complexities of atopic dermatitis: Shifting paradigms in treatment approachesJournal of Allergy and Clinical Immunology, 2014
- A double‐blind, placebo‐controlled trial of montelukast in adult atopic eczemaClinical & Experimental Allergy, 2007
- Effectiveness of montelukast in the treatment of atopic dermatitisMymensingh Medical Journal, 2007
- A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis.2007
- A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseasesBritish Journal of Dermatology, 2006
- Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.2005
- Severity Scoring of Atopic Dermatitis: The SCORAD IndexDermatology, 1993